Scarica l'app Stockscreener
0.6161
1.90%
0.0115
Precedente Chiudi:
$0.6046
Aprire:
$0.62
Volume 24 ore:
189.92K
Relative Volume:
0.25
Capitalizzazione di mercato:
$20.53M
Reddito:
$570.00K
Utile/perdita netta:
$-26.74M
Rapporto P/E:
-0.9454
EPS:
-0.6517
Flusso di cassa netto:
$-33.12M
1 W Prestazione:
+5.37%
1M Prestazione:
+5.14%
6M Prestazione:
+94.97%
1 anno Prestazione:
-64.59%
Intervallo 1D:
$0.604
$0.6299
Intervallo di 1 settimana:
$0.58
$0.63
Portata 52W:
$0.2805
$1.9933
Vyne Therapeutics Inc Stock (VYNE) Company Profile
Nome
Vyne Therapeutics Inc
Settore
Industria
Telefono
800-775-7936
Indirizzo
685 ROUTE 202/206 N., SUITE 301, BRIDGEWATER
Compare VYNE vs VRTX, REGN, ALNY, ARGX, INSM
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
VYNE
Vyne Therapeutics Inc
|
0.6161 | 20.15M | 570.00K | -26.74M | -33.12M | -0.6517 |
VRTX
Vertex Pharmaceuticals Inc
|
454.97 | 115.58B | 12.07B | 3.95B | 3.19B | 15.33 |
REGN
Regeneron Pharmaceuticals Inc
|
749.47 | 79.23B | 14.34B | 4.50B | 3.77B | 41.56 |
ALNY
Alnylam Pharmaceuticals Inc
|
328.70 | 43.59B | 3.71B | 313.75M | 465.38M | 2.2571 |
ARGX
Argen X Se Adr
|
697.05 | 43.26B | 4.16B | 1.29B | 734.26M | 19.58 |
INSM
Insmed Inc
|
148.31 | 31.97B | 606.42M | -1.28B | -997.58M | -6.403 |
Vyne Therapeutics Inc Stock (VYNE) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-07-31 | Downgrade | BTIG Research | Buy → Neutral |
| 2024-11-18 | Iniziato | BTIG Research | Buy |
| 2021-12-06 | Ripresa | H.C. Wainwright | Buy |
Vyne Therapeutics Inc Borsa (VYNE) Ultime notizie
If You Invested $1,000 in Vyne Therapeutics Inc (VYNE) - Stock Titan
Setup Watch: What is the long term forecast for VYNE Therapeutics Inc stockEarnings Miss & Technical Confirmation Trade Alerts - baoquankhu1.vn
VYNE SEC FilingsVyne Therapeutics Inc 10-K, 10-Q, 8-K Forms - Stock Titan
Gains Report: Will VYNE Therapeutics Inc face regulatory challenges2026 Volume Leaders & AI Enhanced Market Trend Forecasts - baoquankhu1.vn
Aug Big Picture: What are analysts price targets for VYNE Therapeutics IncPortfolio Risk Report & Weekly Setup with High ROI Potential - baoquankhu1.vn
VYNE Therapeutics Granted Nasdaq Extension to Regain Compliance - The Globe and Mail
VYNE Therapeutics Inc. Files Form 8-K: Notice of Delisting from NASDAQ and Company Information (March 11, 2026) - Minichart
VYNE Therapeutics Disclosed Failure to Satisfy a Continued Listing Rule or Standard - TradingView
Nasdaq grants VYNE Therapeutics (VYNE) more time to fix sub-$1 share price - Stock Titan
Entry Recap: Can VYNE Therapeutics Inc sustain earnings growthOptions Play & Advanced Swing Trade Entry Alerts - baoquankhu1.vn
Aug Outlook: Can VYNE Therapeutics Inc expand its profit marginsQuarterly Portfolio Review & Scalable Portfolio Growth Ideas - baoquankhu1.vn
Dividend Watch: What is the long term forecast for VYNE Therapeutics Inc stockJuly 2025 Closing Moves & Stepwise Swing Trade Plans - baoquankhu1.vn
Vyne Therapeutics Inc expected to post a loss of 18 cents a shareEarnings Preview - TradingView
Technical Analysis: What analysts say about VYNE Therapeutics Inc stockJuly 2025 Trends & Low Drawdown Momentum Trade Ideas - baoquankhu1.vn
VYNE Earning Date, Earning Analysis and Earning Prediction - Intellectia AI
VYNE Should I Buy - Intellectia AI
VYNE Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
VYNE: Losses narrowed in 2025 as the company pivots to a merger with Yarrow and exits key R&D programs - TradingView
VYNE Therapeutics Inc. Reports Earnings Results for the Full Year Ended December 31, 2025 - marketscreener.com
VYNE Therapeutics (VYNE) to Release Quarterly Earnings on Thursday - Defense World
Aug Analyst Calls: Is Magnite Inc on track to beat earningsWeekly Profit Analysis & Verified Technical Signals - baoquankhu1.vn
Financial Contrast: Qualigen Therapeutics and VYNE Therapeutics - National Today
How VYNE Therapeutics Inc. stock performs in rate cut cyclesWatch List & Consistent Income Trade Recommendations - mfd.ru
Reviewing Avalo Therapeutics (NASDAQ:AVTX) and VYNE Therapeutics (NASDAQ:VYNE) - Defense World
Why is VYNE Therapeutics Inc. stock going upTrade Signal Summary & Proven Capital Preservation Methods - mfd.ru
VYNE Therapeutics Inc. (NASDAQ:VYNE) Sees Large Decline in Short Interest - Defense World
Published on: 2026-02-14 10:12:41 - mfd.ru
What analysts say about VYNE Therapeutics Inc. stockWeekly Stock Analysis & Accurate Intraday Trading Signals - mfd.ru
Can VYNE Therapeutics Inc. deliver consistent dividendsJuly 2025 Highlights & Detailed Earnings Play Alerts - mfd.ru
Published on: 2026-02-12 18:59:51 - mfd.ru
Can VYNE Therapeutics Inc. benefit from deglobalizationPortfolio Update Report & Capital Efficient Trading Techniques - mfd.ru
Published on: 2026-02-09 22:57:29 - baoquankhu1.vn
What analysts say about VYNE Therapeutics Inc stockEarnings Growth Summary & Smart Money Movement Tracker - baoquankhu1.vn
Portfolio Recap: Why is VYNE Therapeutics Inc stock going upBuy Signal & Reliable Momentum Entry Alerts - baoquankhu1.vn
Trade Report: What is the long term forecast for VYNE Therapeutics Inc stockInflation Watch & High Conviction Buy Zone Alerts - baoquankhu1.vn
VYNE Therapeutics Amends Merger Terms with Yarrow Bioscience - The Globe and Mail
Does MTCH stock have upside surprise potentialQuarterly Trade Report & Free Technical Pattern Based Buy Signals - baoquankhu1.vn
VYNE Therapeutics Signs Amendment to Merger Agreement With Yarrow Bioscience - TradingView
Breakout Zone: Is VYNE Therapeutics Inc stock showing strong momentumTrade Performance Summary & Stock Market Timing Techniques - baoquankhu1.vn
How cyclical is VYNE Therapeutics Inc.’s revenue stream2025 Winners & Losers & Long-Term Growth Portfolio Plans - mfd.ru
Short Interest in VYNE Therapeutics Inc. (NASDAQ:VYNE) Decreases By 55.4% - Defense World
Support Test: Can SunCar Technology Group Inc. scale operations efficientlyMarket Movers & Verified Swing Trading Watchlists - baoquankhu1.vn
12 Health Care Stocks Moving In Monday's After-Market Session - Benzinga
Block Trades: Is VersaBank a potential multi baggerJuly 2025 Institutional & Technical Buy Zone Confirmations - baoquankhu1.vn
Is Sonoco Products Company exposed to currency risksMarket Growth Report & Verified Entry Point Signals - baoquankhu1.vn
Volume Summary: Is VYNE Therapeutics Inc stock showing strong momentumWeekly Risk Report & Real-Time Volume Trigger Notifications - baoquankhu1.vn
Analysis Recap: What is the long term forecast for VYNE Therapeutics Inc stockQuarterly Growth Report & Fast Entry High Yield Stock Tips - baoquankhu1.vn
Weekly Earnings: Is SEALPRB stock a value trapJuly 2025 Gainers & Free Safe Capital Growth Stock Tips - baoquankhu1.vn
Aug EndMonth: Why is VYNE Therapeutics Inc stock going upWeekly Gains Report & Fast Momentum Entry Tips - baoquankhu1.vn
Is VYNE Therapeutics Inc. stock positioned well for digital economyJuly 2025 Pullbacks & Safe Entry Trade Reports - Улправда
Will VYNE Therapeutics Inc. stock remain a Wall Street favoriteJuly 2025 Trends & AI Enhanced Trading Alerts - Улправда
Vyne Therapeutics Inc Azioni (VYNE) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.82%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):